Eagle Pharmaceuticals Inc (EGRX)
0.85
+0.05
(+6.25%)
USD |
OTCM |
Nov 07, 16:00
Eagle Pharmaceuticals Revenue (Annual)
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2022 | 316.61M |
December 31, 2021 | 171.55M |
December 31, 2020 | 187.80M |
December 31, 2019 | 195.89M |
December 31, 2018 | 213.31M |
December 31, 2017 | 236.71M |
Date | Value |
---|---|
December 31, 2016 | 189.48M |
December 31, 2015 | 66.23M |
September 30, 2014 | 19.10M |
September 30, 2013 | 13.68M |
September 30, 2012 | 2.539M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
171.55M
Minimum
2021
316.61M
Maximum
2022
217.96M
Average
191.85M
Median
Revenue (Annual) Benchmarks
Eli Lilly and Co | 34.12B |
Verrica Pharmaceuticals Inc | 5.124M |
NovaBay Pharmaceuticals Inc | 14.73M |
Palatin Technologies Inc | 4.490M |
iBio Inc | 0.225M |